References
- Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: An independent review. Br J Cancer 2013;108:2205–40.
- Kemp Jacobsen K, O'meara ES, Key D, Buist SM, Kerlikowske K, Vejborg I, et al. Comparing sensitivity and specificity of screening mammography in the United States and Denmark. Int J Cancer 2015;137:2198–207.
- Hubbard RA, Miglioretti DL, Smith RA. Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res 2010;19:429–49.
- Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen 2007;14:94–7.
- Bolejko A, Zackrisson S, Hagell P, Wann-Hansson C. A roller coaster of emotions and sense–coping with the perceived psychosocial consequences of a false-positive screening mammography. J Clin Nurs 2014;23:2053–62.
- Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013;11:106–15.
- Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026–34.
- Bond M, Pavey T, Welch K, Cooper C, Garside R, Dean S, et al. Psychological consequences of false-positive screening mammograms in the UK. Evid Based Med 2013;18:54–61.
- Bond M, Pavey T, Welch K, Cooper C, Garside R, Dean S, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess 2013;17:1–vi.
- Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening-viewpoint of the IARC Working Group. N Engl J Med 2015;372:2353–8.
- von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol 2006;21: 203–9.
- Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39:38–41.
- WHO. http://www.whocc.no/ddd/definition_and_general_considera/. [Date accessed: 10-3-2014]
- Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med 2001;16:150–6.
- Andersen SB, Vejborg I, von Euler-Chelpin M. Participation behaviour following a false positive test in the Copenhagen mammography screening programme. Acta Oncol 2008;47:550–5.
- Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, et al. Hormone replacement therapy and false positive recall in the Million Women Study: Patterns of use, hormonal constituents and consistency of effect. Breast Cancer Res 2006;8:R8.
- Njor SH, Pedersen AT, Schwartz W, Hallas J, Lynge E. Minimizing misclassification of hormone users at mammography screening. Int J Cancer 2009;124:2159–65.
- Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E. Overdiagnosis in screening mammography in Denmark: Population based cohort study. BMJ 2013;346:f1064.
- Lokkegaard E, Lidegaard O, Moller LN, Agger C, Andreasen AH, Jorgensen T. Hormone. Hormone replacement therapy in Denmark, 1995-2004. Acta Obstet Gynecol Scand 2007;86:1342–51.